Research Article

Association Between Anti-Proliferative Activity of Evernia Prunastri with the Cellular Apoptotic Pathway

Volume: 38 Number: 3 September 30, 2017
  • Önder Yumrutaş
  • Celal Güven
  • Yusuf Özay
  • İşıl Albeniz
  • Müfide Aydoğan Ahbab
  • İbrahim Bozgeyik
  • Atilla Yıldız
  • Haydar Bağış
  • Leyla Türker Şener
EN TR

Association Between Anti-Proliferative Activity of Evernia Prunastri with the Cellular Apoptotic Pathway

Abstract

Evernia prunastri (L.) Ach, belonging to Parmeliaceae, is an important lichen species in Turkey. Previous studies was reported that E. prunastri have significant antioxidant, antimicrobial and anticancer compounds in its structure. Although antiproliferative effects of E. prunastri are determined in some types of cancer, there is little information about the pathway of this activity. Accordingly, we aimed to determine the association between anti-proliferative activities of E. prunastri extracts with the cellular apoptotic pathway. Determination of cell viability was assessed by MTT assay. The xCELLigence system was used to monitor cell proliferation. To reveal induction apoptosis, expression of apoptotic pathway proteins, F-actin staining, ANNEXIN V/propodium iodide (PI) staining was used. As a result, E. prunastri MeOH extracts were found to have anti-proliferative activities especially in high doses (p<0.05 for 1, 5 and 25 µg ml-1; p<0.01 for 125 µg ml-1). Also, the extracts were found to be not inducing apoptosis in flow cytometric measurements. In addition, there was no significant decrease or increase in protein expressions of apoptotic pathway proteins. Lastly, density of actin filaments was not affected. MeOH extract of E. prunastri was found to have anti-proliferative activities, yet these anti-proliferative activities were not related to cellular apoptotic pathways.

Keywords

References

  1. [1]. R.L. Siegel, K.D. Miller, A. Jemal. Cancer statistics. Cancer J Clin. 1986, 65: 5-29.
  2. [2]. American Cancer Society, 2016. Breast Cancer Facts & Figures 2015-2016. Atlanta: American Cancer Society, Inc. Avaliable at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2015-2016.pdf.
  3. [3]. M.J. Bak, S.D. Gupta, J. Wahler, N. Suh. Role of dietary bioactive natural products in estrogen receptor-positive breast cancer. Semin Cancer Biol. 2016,41,170-191.
  4. [4]. G. Shrestha, L.L. St Clair. Lichens: a promising source of antibiotic and anticancer drugs. Phytochem Rev. 2013, 12, 229-244.
  5. [5]. K.O. Vartia, Antibiotics in lichens. In: Ahmadjian V, Hale ME (ed.), The Lichens, New York, Academic Press, 1973, pp. 547-561
  6. [6]. V. Shukla, G.P. Joshi, M.S.M. Rawat. Lichens as a potential natural source of bioactive compounds: a review. Phytochem Rev. 2010, 9, 303-314.
  7. [7]. V. Cardile, A.C.E.Graziano, R. Avola, M. Piovano, A. Russo. Potential anticancer activity of lichen secondary metabolite physodic acid. Chem Biol Interact. 2017, 263, 36-45.
  8. [8]. M. Bessadottir, E.A. Skuladottir, S. Gowan, S. Eccles, S. Omarsdottir, H.M. Ogmundsdottir. Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells Phytomedicine. 2014, 21, 1717-1724.

Details

Primary Language

English

Subjects

-

Journal Section

Research Article

Authors

Celal Güven

Yusuf Özay

İşıl Albeniz

Müfide Aydoğan Ahbab

İbrahim Bozgeyik

Atilla Yıldız

Haydar Bağış

Leyla Türker Şener

Publication Date

September 30, 2017

Submission Date

March 9, 2017

Acceptance Date

June 29, 2017

Published in Issue

Year 1970 Volume: 38 Number: 3

APA
Yumrutaş, Ö., Güven, C., Özay, Y., Albeniz, İ., Aydoğan Ahbab, M., Bozgeyik, İ., Yıldız, A., Bağış, H., & Türker Şener, L. (2017). Association Between Anti-Proliferative Activity of Evernia Prunastri with the Cellular Apoptotic Pathway. Cumhuriyet Science Journal, 38(3), 516-524. https://doi.org/10.17776/csj.340502

Cited By

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December